| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||
|
atypical chemokine receptor 2 | 0.641 | 0.615 | 1.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2018 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2011 | 2018 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
adhesion G protein-coupled receptor F5 | 0.780 | 0.308 | 2.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
anaphase promoting complex subunit 10 | 0.780 | 0.308 | 5.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
arrestin domain containing 2 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
ARVCF delta catenin family member | 0.540 | 0.769 | 5.0E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 binding component 3 | 0.517 | 0.769 | 4.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 like 11 | 0.510 | 0.731 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
chromosome 22 open reading frame 34 | 0.931 | 0.038 | 1.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||||||
|
calpain 3 | 0.564 | 0.615 | 3.6E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 6 | 7 | 2011 | 2018 | |||||||||
|
coiled-coil domain containing 69 | 1.000 | 0.038 | 4.9E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
C-C motif chemokine receptor 2 | 0.418 | 0.846 | 2.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
C-C motif chemokine receptor 3 | 0.527 | 0.808 | 1.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |